Seventure Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Cytoki Pharmacytokipharma.cominMay 2021 · $45M
Cytoki is a biotech company developing IL-22-based therapeutics using lipidation technology to treat metabolic diseases such as obesity and type 2 diabetes, as well as conditions involving epithelial injury like inflammatory bowel disease.
BiotechHealthtechVærløse, DK
Rasmus Jorgensen(CEO & Founder)
Co-investors+ND CapitalYsios Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.